7 new stories
1. Hoteliers beware! Scams targeting Booking.com on the rise ahead of Easter
Domain: cyberdaily.au | Companies: MicrosoftAnalysts at Microsoft have been tracking a phishing campaign targeting hotel owners via online travel service Booking.com. The campaign – tracked by Microsoft as Storm-1865 – uses a social engineering technique known as ClickFix ...
2. Finding the calm in the light storm
Domain: news.exeter.ac.ukScientists have found a new way to navigate beams of light through dynamic scattering media, such as the turbulent atmosphere or living tissue. A team of physicists, led by Professor David Phillips and Professor Simon Horsley from the University of ...
3. Sony launches $7.5 million partnership with Steinhardt
Domain: nyunews.comThe new Sony Audio Institute will offer state-of-the-art equipment, networking opportunities and new research initiatives for Music Technology and Music Business majors. ... An N.Y.U. flag hangs above the Steinhardt School of Culture, Education, and Human ...
4. MacBook Air M4 Review: More Power, Less Money
Domain: wsj.comWhen someone asks what laptop to buy, my default answer is the MacBook Air. And the latest model is even cheaper and better than before. The new M4 MacBook Air has a faster chip, updated webcam and double the RAM—and it costs $100 less.
5. Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
Domain: pennmedicine.orgNearly 90 percent of pancreatic cancers are driven by KRAS mutations, the most common cancer-causing gene mutation across cancer types, which researchers long considered “undruggable.” In 2021, the first KRAS inhibitor was ...
6. Global sea level rose faster than expected in 2024, according to NASA analysis
Domain: abcnews.go.comClimate Minute: Rising sea levels and floodingClimate change is leading to flooding even without big storms. Climate change was a major ...
7. Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine ...
Domain: globenewswire.comOptimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cells; Gradalis applies a novel clinically relevant approach to determine clonal tumor mutation burden/neoantigens, thereby potentially expanding the ...